Celularity (CELU) Tax Provisions (2019 - 2024)
Celularity's (CELU) quarterly Tax Provisions came in at -$12.2 million in Q4 2024, down 121660.0% year-over-year from N/an in Q1 2024, and down 121660.0% quarter-over-quarter from $10000.0 in Q4 2023.
Analysis
Celularity (CELU) Tax Provisions (2019 - 2024) Analysis & Trends
Celularity (CELU) has reported Tax Provisions for 6 consecutive years, with -$12.2 million the latest figure, recorded in Q4 2024.
- On a quarterly basis, Tax Provisions fell 121660.0% year-over-year to -$12.2 million in Q4 2024; TTM through Dec 2024 was -$12.2 million, a 121660.0% decrease from a year earlier, with the FY2025 full-year figure at -$19.3 million, down 58.51% from the prior year.
- Tax Provisions was -$12.2 million for Q4 2024 at Celularity, down from $10000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $272639.0 in Q1 2020 and troughed at -$12.2 million in Q4 2024.
- A 5-year average of -$994377.6 and a median of $11500.0 in 2022 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions soared 214.49% in 2021 and sank 121660.0% in 2024, its largest moves.
- Over 5 years, Tax Provisions stood at -$69000.0 in 2020, then jumped by 128.99% to $20000.0 in 2021, then plunged by 35.0% to $13000.0 in 2022, then declined by 23.08% to $10000.0 in 2023, then slumped by 121660.0% to -$12.2 million in 2024.
- The last three Tax Provisions figures came in at -$12.2 million (Q4 2024), $10000.0 (Q4 2023), and $13000.0 (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.38 Bn | 112.79 Mn | 11.31 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 1.00 Mn |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | -1.40 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | -22.30 Mn |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | 1.84 Mn |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.15 Bn | 1.35 Bn | 251.87 Mn | 3.14 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | - |
| 10 | Celularity | 36.61 Mn | 30.43 Mn | -3.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -12.16 Mn |
| Dec 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 13,000.00 |
| Sep 30, 2022 | -17,000.00 |
| Jun 30, 2022 | 17,000.00 |
| Dec 31, 2021 | 20,000.00 |
| Jun 30, 2021 | 43,700.00 |
| Mar 31, 2021 | -43,700.00 |
| Dec 31, 2020 | -69,000.00 |
| Sep 30, 2020 | 15,000.00 |
| Jun 30, 2020 | -38,170.00 |
| Mar 31, 2020 | 272,639.00 |
| Dec 31, 2019 | 201,523.00 |
| Sep 30, 2019 | 298,032.00 |
| Jun 30, 2019 | 168,675.00 |